ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STJ ST. Jude Medical, Inc.

80.82
0.00 (0.00%)
06 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ST. Jude Medical, Inc. NYSE:STJ NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 80.82 0 01:00:00

Robbins Arroyo LLP: Acquisition of Thoratec Corp. (THOR) by St. Jude Medical, Inc. (STJ) May Not Be in Shareholders' Best Int...

22/07/2015 7:21pm

PR Newswire (US)


SJM (NYSE:STJ)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more SJM Charts.

SAN DIEGO and PLEASANTON, Calif., July 22, 2015 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Thoratec Corp. (NASDAQ: THOR) by St. Jude Medical, Inc. (NYSE: STJ).  On July 22, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which St. Jude will acquire Thoratec.  Under the terms of the agreement, Thoratec shareholders will receive $63.50 for each share of Thoratec common stock.

Robbins Arroyo LLP.

View this information on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/thoratec-corporation

Is the Proposed Acquisition Best for Thoratec and Its Shareholders?

Robbins Arroyo LLP's investigation focuses on whether the board of directors at Thoratec is undertaking a fair process to obtain maximum value and adequately compensate its shareholders.  Notably, the $63.50 merger consideration represents a premium of only 10.3% based on Thoratec's closing price on July 21, 2015.  This premium is significantly below the average one-day premium of nearly 30% for comparable transactions within the past five years.

Thoratec shareholders have the option to file a class action lawsuit to ensure the board of directors obtains the best possible price for shareholders and the disclosure of material information.  Thoratec shareholders interested in information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, ddonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The law firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  

Attorney Advertising. Past results do not guarantee a similar outcome.   

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
600 B Street, Suite 1900
San Diego, CA 92101
ddonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36754LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/robbins-arroyo-llp-acquisition-of-thoratec-corp-thor-by-st-jude-medical-inc-stj-may-not-be-in-shareholders-best-interests-300117218.html

SOURCE Robbins Arroyo LLP

Copyright 2015 PR Newswire

1 Year SJM Chart

1 Year SJM Chart

1 Month SJM Chart

1 Month SJM Chart

Your Recent History

Delayed Upgrade Clock